Jones Lang LaSalle (JLL) had its price target raised by UBS Group AG from $425.00 to $445.00. They now have a "buy" rating on the stock.
Life sciences lab real estate is clawing back from disaster. Here's what that means for investors Share [CNBC]
JLL Wins Tampa Logistics Hub Mandate As Shares Trade Below Targets [Yahoo! Finance]
Hines Secures $55.75M for Prime Oxnard Multifamily Real Estate [Los Angeles Times (CA)]
The power has swung back to employers—and workers are paying for it in benefits, flexibility, and leverage [Yahoo! Finance]